A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
~26 mi.
(Santiago de Compostela,
Spain,
+383 more cities)
Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
~26 mi.
(Santiago de Compostela,
Spain,
+147 more cities)
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
~26 mi.
(Santiago de Compostela,
Spain,
+199 more cities)
Complejo Hospitalario Universitario de Santiago ( Site 0668)
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
~26 mi.
(Santiago de Compostela,
Spain,
+260 more cities)
Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC
~26 mi.
(Santiago de Compostela,
Spain,
+35 more cities)
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
~26 mi.
(Santiago de Compostela,
Spain,
+150 more cities)
Hospital Clinico Universitario de Santiago ( Site 1207)
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
~26 mi.
(Santiago de Compostela,
Spain,
+81 more cities)
Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
~26 mi.
(Santiago de Compostela,
Spain,
+160 more cities)